Sensei Biotherapeutics stock holds at USD 0.48 as cash data guide the story

Published on 09/22/2026 at 06:57 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Sensei Biotherapeutics stock is priced at USD 0.48 on September 21, 2026. Its latest reported figures remain central to the valuation.

SNSE, US81728A1088, Illustration mit AI erstellt.

Sensei Biotherapeutics stock, tied to ISIN US81728A1088, closed at USD 0.48 on Nasdaq on September 21, 2026, according to the latest dated market quotation available for the company. The price level gives the stock a concrete reference point for September 22, 2026, while the company remains a clinical-stage biotechnology issuer.

Price level sets the reference

The September 21, 2026 Nasdaq close of USD 0.48 is the article's reference price for Sensei Biotherapeutics. The quotation is a market figure rather than a statement about future value, and it must be read alongside the company's development-stage operating profile.

A second market comparison is provided by the broader data set for the ticker family: the available September 22, 2026 market snapshot lists a price of USD 9.78, market capitalization of USD 517.11 million, and a 52-week range of USD 4.79 to USD 11.58 for Senseonics Holdings rather than Sensei Biotherapeutics. Those figures are excluded from the company assessment because they belong to a different issuer.

Clinical data remain material

Sensei Biotherapeutics is a biotechnology company whose investment case depends on clinical development, regulatory progress and financing capacity rather than established commercial revenue. The latest search evidence does not provide a period-labeled revenue, earnings, margin or cash figure that can be safely assigned to the company as of September 22, 2026.

For that reason, the dated Nasdaq close is the clearest substantiated numerical market signal in this article. The comparison between the USD 0.48 Sensei quotation on September 21, 2026 and the separate USD 9.78 Senseonics quotation on September 22, 2026 is not a company performance comparison and should not be interpreted as one.

Stock remains a clinical valuation

Sensei Biotherapeutics stock stood at USD 0.48 on Nasdaq as of September 21, 2026. The price is the relevant dated market value for the issuer identified by ISIN US81728A1088, while clinical milestones and financing disclosures remain the key operating variables for interpreting the quotation.